To monitor early renal pathology in the low-dose AA-induced CKD model, we performed in vivo bioluminescence imaging of Saa3 promoter-luciferase transgenic mice (Saa3 promoter-luc mice) four weeks after repeated low-dose AA treatment. The gene discussed is SAA3P; the disease is chronic kidney disease.